Find link

Find link is a tool written by Edward Betts.

Dual orexin receptor antagonist is a redirect to Orexin antagonist

searching for Dual orexin receptor antagonist 4 found (7 total)

alternate case: dual orexin receptor antagonist

SB-649,868 (288 words) [view diff] exact match in snippet view article find links to article

SB-649,868 is a dual orexin receptor antagonist in development by GlaxoSmithKline. The drug is currently in phase II development for insomnia. A phase
Suvorexant (712 words) [view diff] exact match in snippet view article find links to article
Suvorexant (trade name Belsomra) is a selective dual orexin receptor antagonist marketed by Merck & Co. for the treatment of insomnia. It is effective
Hypocretin (orexin) receptor 2 (1,173 words) [view diff] no match in snippet view article find links to article
marketwatch.com/story/eisai-demonstrates-efficacy-of-investigational-dual-orexin-receptor-antagonist-e2006-in-sleep-initiation-and-maintenance-data-from-phase-
Orexin (3,869 words) [view diff] case mismatch in snippet view article find links to article
DJ (2011). "The First Large-Scale Synthesis of MK-4305: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Disorder". Organic Process Research